Nicotine Alone and in Combination with -DOPA Methyl Ester or the D2 Agonist N-0923 in MPTP-Induced Chronic Hemiparkinsonian Monkeys
- 31 August 1999
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 158 (2) , 414-421
- https://doi.org/10.1006/exnr.1999.7106
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Presynaptic nicotinic ACh receptorsPublished by Elsevier ,1997
- The NMDA antagonist dizocilpine (M K801) attenuates tolerance to nicotine in ratsJournal of Psychopharmacology, 1996
- Nicotine Enhancement of Fast Excitatory Synaptic Transmission in CNS by Presynaptic ReceptorsScience, 1995
- N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's diseaseMovement Disorders, 1994
- Nicotine, Parkinson's and Alzheimer's DiseaseReviews in the Neurosciences, 1992
- Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in ratsLife Sciences, 1992
- BIOGENIC AMINE ADDUCTS, MONOAMINE OXIDASE INHIBITORS, AND SMOKINGThe Lancet, 1988
- Irreversible inhibition of monoamine oxidase by some components of cigarette smokeLife Sciences, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Low platelet monoamine oxidase activity in cigarette smokersLife Sciences, 1981